Onderneming Roche Holding AG Xetra
Aandelen
RHO
CH0012032113
Farmaceutische producten
Vakgebied
Aantal werknemers: 103 605
Verkoop per activiteit
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4,83% |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20,43% |
Verkoop per regio
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3,28% |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6,05% |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9,76% |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30,81% |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3,52% |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12,81% |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20,26% |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33,09% |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23,96% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-03 | |
Severin Schwan
CHM | Chairman | 57 | 01-01-08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01-04-11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01-01-20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01-01-15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01-04-20 |
General Counsel | 60 | 01-04-20 | |
Human Resources Officer | 57 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03-03-15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01-01-96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17-03-20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05-03-19 |
Severin Schwan
CHM | Chairman | 57 | 01-01-08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14-03-17 |
Director/Board Member | 58 | 01-03-16 | |
Jemilah Mahmood
BRD | Director/Board Member | - | - |
Akiko Iwasaki
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Aandeel B | 1 | 702 562 700 | 690 549 764 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 005 670 000 | 59.89% | 38 367 557 531 $ | |
ROCHE HOLDING AG 1.43% | 10 073 029 | 1.43% | 2 568 862 838 $ |
2 744 120 | 8.17% | 38 884 180 $ | |
454 961 | 3.02% | 13 357 655 $ | |
ALIGOS THERAPEUTICS, INC. 15.19% | 11 025 941 | 15.19% | 10 805 422 $ |
1 893 | 0.06% | 1 893 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Sapac Corp. Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The private company is based in Woerden, Netherlands. |
Medical Distributors
|
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Catalyst Investments Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Diagnostics India Pvt Ltd.
Roche Diagnostics India Pvt Ltd. Medical SpecialtiesHealth Technology Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The private company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers. |
Medical Specialties
|
Viewics India Pvt Ltd.
| |
Roche Financial Management Ltd.
|
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-3,40% | 157 mld. | |
+8,08% | 167 mld. |